• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Double-blinded Randomized Placebo-controlled Clinical Trial of Omega-3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis.

作者信息

Torrinhas Raquel S, Waitzberg Dan L

机构信息

Department of Gastroenterology Laboratory of Nutrition and Metabolic Surgery of Digestive System (LIM 35) School of Medicine, University of São Paulo, São Paulo, Brazil.

出版信息

J Clin Gastroenterol. 2016 Feb;50(2):180. doi: 10.1097/MCG.0000000000000412.

DOI:10.1097/MCG.0000000000000412
PMID:26448136
Abstract
摘要

相似文献

1
A Double-blinded Randomized Placebo-controlled Clinical Trial of Omega-3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis.
J Clin Gastroenterol. 2016 Feb;50(2):180. doi: 10.1097/MCG.0000000000000412.
2
Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.ω-3脂肪酸治疗非酒精性脂肪性肝炎糖尿病患者的双盲随机安慰剂对照临床试验
J Clin Gastroenterol. 2015 Feb;49(2):137-44. doi: 10.1097/MCG.0000000000000099.
3
In Response.作为回应。
J Clin Gastroenterol. 2016 Feb;50(2):181. doi: 10.1097/MCG.0000000000000451.
4
Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].WELCOME 试验的设计和原理：一项随机、安慰剂对照研究，旨在测试纯化长链ω-3 脂肪酸治疗非酒精性脂肪性肝病的疗效[已更正]。
Contemp Clin Trials. 2014 Mar;37(2):301-11. doi: 10.1016/j.cct.2014.02.002. Epub 2014 Feb 18.
5
Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.长链n-3多不饱和脂肪酸对人类非酒精性脂肪性肝病的治疗作用
Metab Syndr Relat Disord. 2016 Nov;14(9):417-430. doi: 10.1089/met.2016.0051. Epub 2016 Oct 6.
6
Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.非酒精性脂肪性肝病严重程度的改善与颈动脉内膜中层厚度进展的降低相关。
Atherosclerosis. 2016 Mar;246:13-20. doi: 10.1016/j.atherosclerosis.2015.12.028. Epub 2015 Dec 24.
7
Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.ω-3 脂肪酸治疗非酒精性脂肪性肝病：随机对照试验的设计和原理。
BMC Pediatr. 2013 May 23;13:85. doi: 10.1186/1471-2431-13-85.
8
Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.多不饱和脂肪酸疗法对非酒精性脂肪性肝炎患者的疗效。
World J Gastroenterol. 2015 Jun 14;21(22):7008-13. doi: 10.3748/wjg.v21.i22.7008.
9
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.治疗非酒精性脂肪性肝病中的肝脂肪和血清甘油三酯水平，PNPLA3 和 TM6SF2 基因型的影响：来自 WELCOME 试验的结果。
J Hepatol. 2015 Dec;63(6):1476-83. doi: 10.1016/j.jhep.2015.07.036. Epub 2015 Aug 10.
10
Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.饮食切换和 ω-3 羟基脂肪酸在肥胖/非酒精性脂肪肝病小鼠模型中显示出不同的肝保护作用。
World J Gastroenterol. 2018 Jan 28;24(4):461-474. doi: 10.3748/wjg.v24.i4.461.

引用本文的文献

1
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.草药和补充剂对非酒精性脂肪性肝病患者的潜在治疗益处。
Diseases. 2018 Sep 10;6(3):80. doi: 10.3390/diseases6030080.